Clinical Trials
6 trialsNCT04906382 2025-02-13
Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT03631641 2024-07-01
Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy
Ohio State University Comprehensive Cancer Center
Phase 2 Terminated
NCT04508764 2024-04-16
Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
Washington University School of Medicine
Phase NA Terminated
NCT03070574 2019-04-18
MesaCAPP
Medical University of Vienna
Phase 2 Terminated
NCT01026480 2017-03-17
IPAA
Boston Medical Center
Terminated
NCT00566644 2013-07-10
Intrauterine Levonorgestrel and Observation or Observation Alone in Preventing Atypical Endometrial Hyperplasia and Endometrial Cancer in Women With Hereditary Non-Polyposis Colorectal Cancer or Lynch Syndrome
National Cancer Institute (NCI)
Phase 3 Terminated